BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodrigues R, Lai M, Beswick A, Gorman DA, Anagnostou E, Szatmari P, Anderson KK, Ameis SH. Practitioner Review: Pharmacological treatment of attention‐deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta‐analysis. J Child Psychol Psychiatr 2021;62:680-700. [DOI: 10.1111/jcpp.13305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Lord C, Charman T, Havdahl A, Carbone P, Anagnostou E, Boyd B, Carr T, de Vries PJ, Dissanayake C, Divan G, Freitag CM, Gotelli MM, Kasari C, Knapp M, Mundy P, Plank A, Scahill L, Servili C, Shattuck P, Simonoff E, Singer AT, Slonims V, Wang PP, Ysrraelit MC, Jellett R, Pickles A, Cusack J, Howlin P, Szatmari P, Holbrook A, Toolan C, McCauley JB. The Lancet Commission on the future of care and clinical research in autism. Lancet 2021:S0140-6736(21)01541-5. [PMID: 34883054 DOI: 10.1016/S0140-6736(21)01541-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Fu D, Wu D, Guo H, Hu Y, Xia Y, Ji X, Fang W, Li Y, Xu J, Chen F, Liu Q. The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review. Front Psychiatry 2022;12:780921. [DOI: 10.3389/fpsyt.2021.780921] [Reference Citation Analysis]
3 Rosello R, Martinez-Raga J, Mira A, Pastor JC, Solmi M, Cortese S. Cognitive, social, and behavioral manifestations of the co-occurrence of autism spectrum disorder and attention-deficit/hyperactivity disorder: A systematic review. Autism 2021;:13623613211065545. [PMID: 34961363 DOI: 10.1177/13623613211065545] [Reference Citation Analysis]
4 Rosello R, Martinez-Raga J, Tomas JM, Mira A, Cortese S. Cognitive and behavioral profiles in children with autism spectrum disorder with and without Attention-Deficit/hyperactivity disorder. Child Adolesc Ment Health 2022. [PMID: 35441444 DOI: 10.1111/camh.12562] [Reference Citation Analysis]
5 Siafis S, Çıray O, Wu H, Schneider-Thoma J, Bighelli I, Krause M, Rodolico A, Ceraso A, Deste G, Huhn M, Fraguas D, San José Cáceres A, Mavridis D, Charman T, Murphy DG, Parellada M, Arango C, Leucht S. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Mol Autism 2022;13:10. [PMID: 35246237 DOI: 10.1186/s13229-022-00488-4] [Reference Citation Analysis]
6 Aishworiya R, Valica T, Hagerman R, Restrepo B. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder. Neurotherapeutics 2022. [PMID: 35029811 DOI: 10.1007/s13311-022-01183-1] [Reference Citation Analysis]
7 Farhat LC, Bloch MH. Commentary: Identifying individualized predictions of response in ADHD pharmacotherapy - a commentary on Rodrigues et al. (2020). J Child Psychol Psychiatry 2021;62:701-3. [PMID: 33368287 DOI: 10.1111/jcpp.13374] [Reference Citation Analysis]
8 Masi G, Pfanner C, Liboni F, Lenzi F, Villafranca A, D'Acunto G, Fantozzi P, Falcone F, Simonelli V, Muratori P, Levantini V, Favole I, Amianto F, Davico C, Vitiello B. Acute Tolerability of Methylphenidate in Treatment-Naïve Children with ADHD: An Analysis of Naturalistically Collected Data from Clinical Practice. Paediatr Drugs 2022. [PMID: 35137333 DOI: 10.1007/s40272-022-00492-4] [Reference Citation Analysis]